Medical And Research Infomration Consult is categorized under Medical Research in Boston, MA and active since 2013.
Medical And Research Infomration Consult was established in 2013, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Minsheng Yuan at the company’s single location by writing to 380 Riverway Apartment 6, Boston, Massachusetts MA 02115 or by phoning (617) 734-9672. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Medical And Research Infomration Consult |
Contact Person: | Minsheng Yuan |
Address: | 380 Riverway Apartment 6, Boston, Massachusetts 02115 |
Phone Number: | (617) 734-9672 |
Annual Revenue (USD): | $0 to $49.999 |
Founded: | 2013 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Medical And Research Infomration Consult was started in 2013 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Minsheng Yuan for inquiries that concern Medical And Research Infomration Consult by calling the company number (617) 734-9672, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical And Research Infomration Consult can be found at the coordinates 42.332508,-71.112184 as well as the street address 380 Riverway Apartment 6 in Boston, Massachusetts 02115.
For its online presence, you may visit Medical And Research Infomration Consult’s website at and engage with its social media outlets through on Twitter and on Facebook.